Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Depreciation & Amortization (CF) (2016 - 2025)

Haemonetics has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $27.4 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $27.4 million for Q4 2025, down 5.65% from a year ago — trailing twelve months through Dec 2025 was $112.6 million (down 2.1% YoY), and the annual figure for FY2025 was $115.6 million, up 18.9%.
  • Depreciation & Amortization (CF) for Q4 2025 was $27.4 million at Haemonetics, down from $28.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for HAE hit a ceiling of $29.2 million in Q3 2024 and a floor of $21.9 million in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $24.6 million (2022), compared with a mean of $25.5 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 23.83% in 2021 and later grew 26.96% in 2024.
  • Haemonetics' Depreciation & Amortization (CF) stood at $23.5 million in 2021, then increased by 0.15% to $23.6 million in 2022, then dropped by 0.17% to $23.5 million in 2023, then increased by 23.35% to $29.0 million in 2024, then dropped by 5.65% to $27.4 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $27.4 million (Q4 2025), $28.3 million (Q3 2025), and $28.8 million (Q2 2025) per Business Quant data.